Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Schedule of interests subsidiary undertakings (Details)

v3.23.1
Schedule of interests subsidiary undertakings (Details)
 12 Months Ended
Dec. 31, 2022
TC BioPharm Limited [member]  
IfrsStatementLineItems [Line Items]  
Name TC BioPharm Limited
Country of incorporation United Kingdom
Holding Ordinary £1 shares and A Ordinary £0.001 shares
Proportion held 100% by TC BioPharm (Holdings) plc
Nature of business Biotechnology research and development
TC BioPharm North America Inc [member]  
IfrsStatementLineItems [Line Items]  
Name TC BioPharm (North America), Inc.
Country of incorporation United States of America
Holding Ordinary $0.01 shares
Proportion held 100% by TC BioPharm Limited
Nature of business Biotechnology research and development
TC BioPharm BV [member]  
IfrsStatementLineItems [Line Items]  
Name TC BioPharm BV
Country of incorporation The Netherlands
Holding Ordinary €1 shares
Proportion held 100% by TC BioPharm Limited
Nature of business Biotechnology research and development